PriceTargets.com logo

XWELL - XWEL Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $1.00
  • Forecasted Upside: -53.77%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$2.16 As of 09/28/2023 02:11 PM ET
▼ -0.2687 (-11.05%)

This chart shows the closing price for XWEL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New XWELL Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for XWEL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for XWEL

Analyst Price Target is $1.00
▼ -53.77% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for XWELL in the last 3 months. The average price target is $1.00, with a high forecast of $1.00 and a low forecast of $1.00. The average price target represents a -53.77% upside from the last price of $2.16.

This chart shows the closing price for XWEL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in XWELL. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/6/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/5/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/3/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/1/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/1/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/30/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/29/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/28/2023

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/25/2023HC WainwrightReiterated RatingBuy ➝ Buy$1.00Low
4/4/2023HC WainwrightLower TargetBuy$1.50 ➝ $1.00Low
11/16/2022HC WainwrightLower TargetBuy$2.00 ➝ $1.50Low
(Data available from 9/28/2018 forward)

News Sentiment Rating

1.19 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/2/2023
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/1/2023
  • 4 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/1/2023
  • 4 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/31/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/30/2023
  • 3 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/30/2023
  • 4 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/29/2023
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/28/2023

Current Sentiment

  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

XWELL logo
XWELL, Inc., a health and wellness services company, provides spa services at airports. It operates through XpresSpa, XpresTest, Treat, and HyperPointe segments. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also provides diagnostic COVID-19 tests at XpresCheck wellness centers in airports; and other medical diagnostic testing services. In addition, the company offers marketing support to health and health-related channels. It operates stores, as well as offers its services through an integrated digital platform. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. was founded in 2006 and is headquartered in New York, New York.
Read More

Today's Range

Now: $2.16
Low: $2.09
High: $2.25

50 Day Range

MA: $0.21
Low: $0.12
High: $0.30

52 Week Range

Now: $2.16
Low: $2.07
High: $16.61

Volume

92,494 shs

Average Volume

14,056 shs

Market Capitalization

$180.61 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.09

Frequently Asked Questions

What sell-side analysts currently cover shares of XWELL?

The following Wall Street analysts have issued reports on XWELL in the last year: HC Wainwright.
View the latest analyst ratings for XWEL.

What is the current price target for XWELL?

1 Wall Street analysts have set twelve-month price targets for XWELL in the last year. Their average twelve-month price target is $1.00, suggesting a possible downside of 53.8%. HC Wainwright has the highest price target set, predicting XWEL will reach $1.00 in the next twelve months. HC Wainwright has the lowest price target set, forecasting a price of $1.00 for XWELL in the next year.
View the latest price targets for XWEL.

What is the current consensus analyst rating for XWELL?

XWELL currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe XWEL will outperform the market and that investors should add to their positions of XWELL.
View the latest ratings for XWEL.

What other companies compete with XWELL?

Other companies that are similar to XWELL include MEDIROM Healthcare Technologies, Eloxx Pharmaceuticals, Akumin, GeoVax Labs and Surrozen. Learn More about companies similar to XWELL.

How do I contact XWELL's investor relations team?

XWELL's physical mailing address is 254 WEST 31ST STREET 11TH FLOOR, NEW YORK NY, 10001. The company's listed phone number is (212) 750-9595 and its investor relations email address is [email protected]. The official website for XWELL is www.xwell.com. Learn More about contacing XWELL investor relations.